Table 3.
UPSS Median (range) |
UPSA Median (range) |
UPSB Median (range) |
UPSC Median (range) |
|
---|---|---|---|---|
GBS n = 33 |
4, 1–9 | 2, 0–5 | 2, 0–3 | 0, 0–2 |
CIDP <4 weeks n = 17 |
7, 1–20 | 4, 0–15 | 2, 0–3 | 1, 0–3 |
CIDP >4 weeks n = 17 |
8, 2–22 | 5, 1–16 | 2, 0–3 | 1, 0–3 |
All CIDP | 8, 1–22 | 5, 0–16 | 2, 0–3 | 1, 0–3 |
p values* (t test with Bonferroni) |
0.001 0.001 0.001 1.0** |
0.001 0.001 0.001 1.0** |
1.0 0.427 0.313 0.795** |
0.001 0.001 0.001 0.231** |
All CIDP patients, even the subgroups consisting of those with less and those with more than 4 weeks of symptoms, had significantly larger values for UPSA, UPSC, and UPSS, but not for UPSB
GBS = Guillain–Barré syndrome; CIDP = chronic inflammatory demyelinating polyradiculoneuritis
*Comparison of GBS to CIDP < 4 weeks, > 4 weeks, and all CIDPs (p values < 0.05 are significant; nonsignificant differences are in italic). **Between CIDP < 4 weeks and > 4 weeks, no significant differences occur